Furthermore, visceral adiposity, insulin-resistance, and chronic low-grade inflammation represent, among those herein considered, the main factors capable of explaining the increased CERT1 in both OB-MetS− and OB-MetS+ subjects. The gene discussed is CERT1; the disease is metabolic syndrome.